NIB Holdings (NHF) $6.75
NHF rallied 6.3% on Thursday, dragged higher by bullish sentiment towards MPL and their announced +5.8% premium hike starting in April.
NIB Holdings (NHF)
NHF $6.76
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 6.76
- Change
- ▼ -0.01 (-0.15)
- Bid / Ask
- 6.75 - 6.76
- Volume
- 1,147,458
- Turnover
- 7,780,663
- Open
- 6.77
- Day Range
- 6.74 - 6.88
- VWAP
- 6.78
- Prev Close
- 6.77
- Last Trade
- 06/11 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Financial Services
- Shares Issued
- 490,691,380
- NTA/Share
- 1.43
- Last Dividend
- 0.16
- Dividend Ex Date
- 3 SEP 2026
- Dividend Pay Date
- 7 OCT 2026
Current (AUD) · FY2026
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 3,757.90
- EBITDA
- 311.60
- Profit
- 187.50
- Earnings Per Share (EPS)
- 0.38
- Dividend Per Share (DPS)
- 0.29
- Yield %
- 4.29
- Market Cap
- 3,317.07
- Price to Earnings Ratio (P/E)
- 17.86
Estimates (AUD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- —
- EBITDA
- —
- Profit
- 208.19
- Earnings Per Share (EPS)
- 0.43
- Dividend Per Share (DPS)
- 0.30
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Strong
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 5 NOV 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 6.47 Fair value 7.41 One-star price 8.49
Morningstar Quantitative Rating as of 5 NOV 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 7.41
- Price / Fair Value
- 0.91
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 5 NOV 2026. The slider runs from the five-star price (6.47) to the one-star price (8.49).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): AUD/AUD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 6.76 |
| Price - 12 month high | 7.73 |
| Price - 12 month low | 5.79 |
| Pricing date | 5 NOV 2026 |
| Volume - avg. trading volume for the last ten days | 1.00 |
| Market capitalization | 3,317.07 |
| 12 Month High price date | 29 JUL 2026 |
| 12 Month Low price date | 12 MAR 2026 |
| Volume - avg. trading volume for the last 3 months | 0.99 |
| Price - 1 Day % Change | -0.15% |
| Price - 13 week price percent change | -9.50% |
| Price - 26 week price percent change | 0.60% |
| Price - 5 Day % Change | 3.52% |
| Price - 52 week price percent change | -8.03% |
| Price - YTD price percent change | -1.46% |
| Price % Change Month To Date | 6.46% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 0.379 |
| EPS excluding extraordinary items - trailing 12 month | 0.379 |
| EPS Normalized - most recent fiscal year | 0.487 |
| Revenue/share - most recent fiscal year | 7.702 |
| Revenue/share - trailing 12 month | 7.702 |
| Book value per share - most recent fiscal year | 2.357 |
| Book value per share - most recent half-year | 2.357 |
| Book value (tangible) per share - most recent fiscal year | 1.427 |
| Book value (tangible) per share - most recent half-year | 1.427 |
| Cash per share - most recent fiscal year | 0.444 |
| Cash per share - most recent half-year | 0.444 |
| Cash Flow per share - most recent fiscal year | 0.408 |
| Cash Flow per share - trailing 12 month | 0.408 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.290 |
| EBITD per share - trailing 12 month | 0.639 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 0.379 |
| EPS Basic excluding extraordinary items - trailing 12 month | 0.379 |
| EPS including extraordinary items - most recent fiscal year | 0.384 |
| EPS including extraordinary items - trailing 12 month | 0.384 |
| Free Cash Flow per share - trailing 12 month | 0.338 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 17.86 |
| P/E Normalized, most recent fiscal year | 13.89 |
| Price to sales - most recent fiscal year | 0.88 |
| Price to Tangible Book - most fiscal year | 4.74 |
| Price to Free Cash Flow per Share - most recent fiscal year | 20.03 |
| Price to Cash Flow per share - trailing 12 month | 16.57 |
| Price to Book - most recent fiscal year | 2.87 |
| P/E excluding extraordinary items high, trailing 12 months | 19.28 |
| P/E excluding extraordinary items low, trailing 12 months | 14.62 |
| Net Debt, LFI | 110.10 |
| Net Debt, LFY | 12.30 |
| Dividend Yield - 5 Year Average | 3.75% |
| Dividend Yield - indicated annual dividend divided by closing price | 4.34% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 4.29% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 164.70 |
| LT debt/equity - most recent fiscal year | — |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 19.90% |
| LT debt/equity - most recent half-year | — |
| Total debt/total equity - most recent half-year | 25.39% |
| Free Cash Flow - trailing 12 month | 164.70 |
| Payout ratio - trailing 12 month | — |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 3,757.90 |
| Revenue - trailing 12 month | 3,757.90 |
| EBITD - most recent fiscal year | 311.60 |
| EBITD - trailing 12 month | 311.60 |
| Earnings before taxes - most recent fiscal year | 258.40 |
| Earnings before taxes - trailing 12 month | 258.40 |
| Net Income available to common - most recent fiscal year | 187.50 |
| Net Income available to common - trailing 12 months | 187.50 |
| Earnings before taxes Normalized - most recent fiscal year | 332.20 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 0.49 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 4.92% |
| Net Profit Margin % - trailing 12 month | 4.92% |
| Operating margin - 1st historical fiscal year | 8.78% |
| Operating margin - trailing 12 month | 8.78% |
| Pretax margin - trailing 12 month | 6.88% |
| Pretax margin - 1st historical fiscal year | 6.88% |
| Operating Margin - 5 year average | 11.06% |
| Pretax Margin - 5 year average | 7.59% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 6.21% |
| Free Operating Cash Flow/Revenue, TTM | 4.38% |
| Net Profit Margin - 5 year average | 5.34% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 8.60% |
| Return on average assets - trailing 12 month | 8.60% |
| Return on average equity - most recent fiscal year | 16.47% |
| Return on average equity - trailing 12 month | 16.47% |
| Return on average assets - 5 year average | 8.84% |
| Return on average equity - 5 year average | 19.10% |
| Net Income/employee - most recent fiscal year | — |
| Revenue/employee - most recent fiscal year | — |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 7.18% |
| EPS growth rate, 5 year | 1.77% |
| Growth rate% - dividend, 3 year | 6.51% |
| Revenue/share (5 yr growth) | 5.79% |
| Growth rate% - Revenue, 3 year | 6.39% |
| Growth rate% - EPS, 3 year | -1.47% |
| Book value per share growth rate, 5 year | 8.80% |
| Capital Spending growth rate, 5 year | 7.83% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 3.14% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (AUD, millions except per share)
| Actuals | Estimates | |||||||
| 2026 | 2027 | 2028 | ||||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (AUD, millions)
| Period end: | JUN 22 | JUN 23 | JUN 24 | JUN 25 | JUN 26 |
| Fiscal year: | 2022 | 2023 | 2024 | 2025 | 2026 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
| DATE | TIME | HEADING | PAGES |
| Price sensitive |
Opinion
Nib Holdings (NHF) $6.68
NHF +12.46%: Delivered better-than-expected results as Australian Residents Health Insurance (ARHI) margins exceeded expectations, with earnings guidance of $235-$250m maintained for the full-year.
NIB Holdings Ltd (NHF) $5.70
NHF advanced +2.5% on Thursday following the news that a surprising number of young people are taking up private health insurance despite the risks of the cost-of-living crisis pushing patients into the public sector. Official data released on Thursday showed that more than 15 million Australians now have private health cover following a 5% increase in Australians aged in their 20s taking out hospital cover in the quarter.
NIB Holdings Ltd (NHF) $7.92
NHF delivered a mixed 1H24 result last month, with mixed quality and slowing sales momentum. This led to some downgrades and an initial subsequent sharp fall in the stock, most of which has now been recouped.
NIB Holdings Ltd (NHF) $7.47
NHF has struggled through 2023, with the stock down -3.6% year-to-date. At this month's AGM, their overall volume and topline momentum were generally upbeat, but no details were provided on claims costs and margin performance, and as we know, markets hate uncertainty, tending to assume the worst when information is not forthcoming
NIB Holdings Ltd (NHF) $7.67
NHF is the 4th largest private health business in Australia covering both residents and also international students and workers – a larger population equals more potential customers. Revenues and margins declined during COVID, both are now rebounding rapidly, and we see upside risk to consensus if the company can achieve a full normalisation of volumes and margins.
NIB Holdings (NHF) $8.80
NIB has rallied to fresh all-time highs this month with the sharp sell-off following its disappointing earnings report in Q1 a distant memory. The stock has been strongly re-rated on the upside over recent months due to the positive combination of strong migration trends and low claims. The stock isn’t cheap trading on an Est. 21.6x valuation for FY23 but history tells us that buying stocks with strong momentum often makes sense.
NIB Holdings Ltd (NHF) $8.46
NHF rallied +2.9% on Monday posting fresh all-time highs in the process, February’s sharp sell-off following its disappointing earnings report has become a distant memory i.e. a ¬5% miss due to soft margins.
Commonwealth Bank (CBA) v NIB Holdings (NHF)
CBA has dragged the Banking Sector lower this month after disappointing the market last week, similarly, NHF was clobbered -11.6% yesterday following its earnings report, testing below last year’s $150m equity raise price in the process.
NIB Holdings Ltd (NHF) $6.61
NIB Holdings (NHF) fell -11.98% yesterday following a $150m equity raise at $6.90, the stock closed ~4% below the placement price which wouldn’t cheer the fund managers who often enjoy easy pickings from capital raisings. The raise is to fund acquisitions with the first company on the menu being Maple Plan as the health insurer looks to enter into Australia’s National Disability Insurance Scheme Sector.
Action
Updated
28/02/2025
10:15
NHF
Updated 28/02/2025 10:15
MM is neutral NHF around $6.75
Updated
24/02/2025
17:39
NHF
Updated 24/02/2025 17:39
MM cautiously bullish NHF
Updated
02/12/2024
09:12
NHF
Updated 02/12/2024 09:12
New trade idea: Buy NHF ~$5.70 with stops below $5.40; with an initial target ~$6.60.
Updated
29/11/2024
09:24
NHF
Updated 29/11/2024 09:24
MM is cautiously bullish toward NHF ~$5.70
Updated
07/03/2024
09:39
NHF
Updated 07/03/2024 09:39
MM is neutral toward NHF
Updated
23/11/2023
09:34
NHF
Updated 23/11/2023 09:34
MM is neutral toward NHF
Updated
21/09/2023
11:31
NHF
Updated 21/09/2023 11:31
MM likes NHF under $7.50
Updated
20/06/2023
09:00
NHF
Updated 20/06/2023 09:00
MM remains neutral to bullish on NHF
Updated
30/05/2023
09:09
NHF
Updated 30/05/2023 09:09
MM is neutral to bullish toward NHF around $8.50
Updated
21/02/2023
13:29
CBA
Updated 21/02/2023 13:29
MM only has an interest in CBA & NHF 8-10% lower
Business Summary
NIB Holdings is Australia's fourth-largest health fund. It is a national provider of private health insurance, life insurance, travel insurance, and related healthcare services, with a growing presence in New Zealand. Approximately 55% of the population is covered by private health insurance because of taxation benefits, shorter wait times, a choice of doctor and hospital, and cover of ancillary health services.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
